Removal of the GAA repeat in the heart of a Friedreich’s ataxia mouse model using CjCas9
- 14 February 2023
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 30 (7-8) , 612-619
Abstract
Most Friedreich ataxia (FRDA) cases are caused by the elongation of the GAA repeat (GAAr) sequence in the first intron of the FXN gene, leading to a decrease of the frataxin protein expression. Deletion of this GAAr with CRISPR/Cas9 technology leads to an increase in frataxin expression in vitro. We are therefore aiming to develop FRDA treatment based on the deletion of GAAr with CRISPR/Cas9 technology using a single AAV expressing a small Cas9 (CjCas9) and two single guide RNAs (sgRNAs) targeting the FXN gene. This AAV was intraperitoneally administrated to YG8sR (250–300 GAAr) and to YG8-800 (800 GAAr) mice. DNA and RNA were extracted from different organs a month later. PCR amplification of part of intron 1 of the FXN gene detected some GAAr deletion in some cells in heart and liver of both mouse models, but the editing rate was not sufficient to cause an increase in frataxin mRNA in the heart. However, the correlation observed between the editing rate and the distribution of AAV suggests a possible therapy based on the removal of the GAAr with a better delivery tool of the CRISPR/Cas9 system.Keywords
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (418059)
- National Ataxia Foundation
- Ataxia Canada
This publication has 40 references indexed in Scilit:
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co‐localize, suggesting a common Palaeolithic origin in the Franco‐Cantabrian ice age refugeJournal of Neurochemistry, 2013
- Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3Human Molecular Genetics, 2013
- Friedreich AtaxiaJournal of Child Neurology, 2012
- Friedreich ataxia2012
- Expression of Human Frataxin Is Regulated by Transcription Factors SRF and TFAP2PLOS ONE, 2010
- Function and biogenesis of iron–sulphur proteinsNature, 2009
- Friedreich ataxia: The clinical pictureJournal of Neurology, 2009
- Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxiaNucleic Acids Research, 2008
- Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxiaNucleic Acids Research, 2007